Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 3, 2000, Pages 1120-1126

  Cryan, John F ^a   Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 2 CHLORO 5 FLUOROINDOL 1 YL 1 METHYLETHYLAMINE FUMARATE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; FLUOXETINE; MIANSERIN; RO 600332; SB 206533; SEROTONIN 2C AGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG; WAY 161503;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CLIMBING; DRUG EFFECT; DRUG MECHANISM; FORCED SWIMMING TEST; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; STIMULATION; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLAMINES; FLUOXETINE; INDOLES; MALE; MIANSERIN; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SWIMMING;

EID: 0033681079     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. A review of central 5-HT receptors and their function
2. 2 receptor subtypes: A family reunited?
3. Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatelogy of depression in humans?
4. Drug-induced penile erections in rats: Indications of serotonin(1B) receptor mediation
5. Comparison of stimulus properties of fluoxetine and 5-HT receptor agonists in a conditioned taste aversion procedure
6. Evidence that imipramine activates 5-HT(1C) receptor function
7. Is the forced swimming test a suitable model for revealing antidepressant activity?
8. The importance of 5-HT(1C)-receptors for antidepressant effects
9. 1-(3-Trifluoromethylphenyl) piperazine (TFMPP) in the ventral tegmental area reduces the effect of desipramine in the forced swimming test in rats: Possible role of serotonin receptors
10. Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice
11. 5-HT(1A) and beyond - The role of serotonin and its receptors in depression and the antidepressant response
12. Acute and chronic effects of the atypical antidepressant, mianserin on brain noradrenergic neurons
13. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression
14. Active behaviors in the rat forced swimming test differentially produced by serotonergic and oradrenergic antidepressants
15. Chronic effects of mianserin on noradrenaline metabolism in the rat brain: Evidence for a pre-synaptic alpha-adrenolytic action in vivo
16. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats
17. Selective serotonin reuptake inhibitors in affective disorders. I. Basic pharmacology
18. Brain 5-HT(1C) receptors and antidepressants
19. Evidence for a role of 5-HT(1C) receptors in the antiserotonergic properties of some antidepressant drugs
20. 5-HT(1C) receptors and their therapeutic relevance
21. Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT(2C)/(2B) receptor function
22. In vitro and in vivo profile of SB 206553, a potent 5-HT 2C/5-HT2B receptor antagonist with anxiolytic-like properties
23. Fluoxetine suppressed palatability-induced ingestion
24. Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers
25. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HC1 (DOI)
26. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs
27. The spectrum of behaviors influenced by serotonin
28. Reduction of feeding behavior by the serotonin uptake inhibitor sertraline
29. Behavioral studies of serotonin receptor agonists as antidepressant drugs
30. Effect of 1-(m-chiorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity
31. Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance
32. The serotonin hypothesis of major depression
33. Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations
34. 5-HT(2C) receptor agonists: Pharmacological characteristics and therapeutic potential
35. The distribution and cellular localization of the serotonin(1C) receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution
36. 5HT(2C) receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats
37. Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans
38. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test
39. The binding of serotonergic ligands to the porcine ehoroid plexus: Characterisation of a new type of serotonin recognition site
40. Depression: A new animal model sensitive to antidepressant treatments
41. SSRI treatment decreases prolactin and hyperthermic responses to m-CPP
42. Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test
43. Antiobesity-like effects of the selective 5-HT2C agonist WAY 161503
44. Anpirtoline, a novel, highly potent 5-HT1B receptor agonist with antinociceptive/antidepressant-like actions in rodents
45. Comparison of the 5-HT(2C) antagonist properties of the 5-HT(2C)/(2B) antagonist SB 206533 and RS-102221in rats
46. Animal models of depression and schizophrenia